Benefit of Bone Drug in Prostate Cancer in Doubt
(medpagetoday.co) WASHINGTON (MedPage Today) -- FDA reviewers have questioned whether expanding the indication for Amgen's denosumab (Xgeva) to prevent the spread of prostate cancer to the bones would provide much added benefit.
Update update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 15793 failed: 1142 [UPDATE command denied to user '334187_hdlns_ms5'@'10.187.248.89' for table 'feed'] in [update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 15793]
updated 15793 (Medical - Health & Policy), inserted 15, updated 0, at 2012-05-31 07:11:04
Articles from: Medical - Health & Policy (medpagetoday.co)